NovaBay Pharmaceuticals (NBY) Current Assets (2016 - 2025)
Historic Current Assets for NovaBay Pharmaceuticals (NBY) over the last 17 years, with Q3 2025 value amounting to $2.9 million.
- NovaBay Pharmaceuticals' Current Assets rose 2716.1% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 2716.1%. This contributed to the annual value of $1.9 million for FY2024, which is 7295.22% down from last year.
- Per NovaBay Pharmaceuticals' latest filing, its Current Assets stood at $2.9 million for Q3 2025, which was up 2716.1% from $6.1 million recorded in Q2 2025.
- Over the past 5 years, NovaBay Pharmaceuticals' Current Assets peaked at $13.2 million during Q4 2021, and registered a low of $1.9 million during Q4 2024.
- In the last 5 years, NovaBay Pharmaceuticals' Current Assets had a median value of $9.5 million in 2022 and averaged $8.4 million.
- Per our database at Business Quant, NovaBay Pharmaceuticals' Current Assets tumbled by 7991.26% in 2024 and then surged by 17141.59% in 2025.
- NovaBay Pharmaceuticals' Current Assets (Quarter) stood at $13.2 million in 2021, then dropped by 13.96% to $11.3 million in 2022, then plummeted by 36.87% to $7.2 million in 2023, then plummeted by 72.95% to $1.9 million in 2024, then soared by 49.77% to $2.9 million in 2025.
- Its Current Assets was $2.9 million in Q3 2025, compared to $6.1 million in Q2 2025 and $9.0 million in Q1 2025.